Multifunctional quantum-dot-based siRNA delivery for HPV18 E6 gene silence and intracellular imaging

Biomaterials

Volumn 32, Issue 31, 2011, Pages 7978-7987

  Li, Jin Ming ^a   Zhao, Mei Xia ^a   Su, Hua ^a   Wang, Yuan Yuan ^a   Tan, Cai Ping ^a   Ji, Liang Nian ^a   Mao, Zong Wan ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Cyclodextrin; Gene silencing; Quantum dots; Real time tracking; SiRNA delivery

Indexed keywords

CDSE/ZNSE; CELLULAR CYTOTOXICITY; ENDOSOMAL RELEASE; FLUORESCENCE PROBES; GENE SILENCE; GENE SILENCING; HELA CELL; IN-VIVO; INTRACELLULAR IMAGING; INTRACELLULAR TRANSPORT; MICROSCOPIC ANALYSIS; MTT ASSAYS; QUANTUM DOT; REAL TIME TRACKING; SIRNA DELIVERY; TARGET GENES; WESTERN BLOTTING;

AMINO ACIDS; GENES; QUANTUM CHEMISTRY; RNA; SEMICONDUCTOR QUANTUM DOTS; TRANSCRIPTION;

GENETIC ENGINEERING;

AMINO ACID; ARGININE; BETA CYCLODEXTRIN; CADMIUM SELENIDE; NANOCRYSTAL; QUANTUM DOT; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ZINC DERIVATIVE; ZINC SELENIDE;

ARTICLE; ASSAY; CELL MEDIATED CYTOTOXICITY; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; FLUORESCENCE; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; WESTERN BLOTTING;

ADSORPTION; BLOTTING, WESTERN; CELL DEATH; CELL SURVIVAL; FLOW CYTOMETRY; FLUORESCENCE; GENE SILENCING; GENE TRANSFER TECHNIQUES; HELA CELLS; HUMANS; IMAGING, THREE-DIMENSIONAL; INTRACELLULAR SPACE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; ONCOGENE PROTEINS, VIRAL; QUANTUM DOTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION;

EID: 80051827676     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.07.011     Document Type: Article

References (39)

1. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806-811.
2. Siomi H., Siomi M.C. On the road to reading the RNA-interference code. Nature 2009, 457:396-404.
3. Kim D.H., Rossi J.J. Strategies for silencing human disease using RNA interference. Nat Rev Genet 2007, 8:173-184.
4. Rana T.M. Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol 2007, 8:23-36.
5. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498.
6. McManus M.T., Sharp P.A. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002, 3:737-747.
7. Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W.S., Khvorova A. Rational siRNA design for RNA interference. Nat Biotechnol 2004, 22:326-330.
8. Tebes S.J., Kruk P.A. The genesis of RNA interference, its potential clinical applications, and implications in gynecologic cancer. Gynecol Oncol 2005, 99:736-741.
9. Novina C.D., Sharp P.A. The RNAi revolution. Nature 2004, 430:161-164.
10. Takakura Y. Towards therapeutic application of RNA-mediated gene regulation. Preface. Adv Drug Deliv Rev 2009, 61:667.
11. Dorsett Y., Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 2004, 3:318-329.
12. Landen C.N., Chavez-Reyes A., Bucana C., Schmandt R., Deavers M.T., Lopez-Berestein G., et al. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res 2005, 65:6910-6918.
13. Zimmermann T.S., Lee A.C., Akinc A., Bramlage B., Bumcrot D., Fedoruk M.N., et al. RNAi-mediated gene silencing in non-human primates. Nature 2006, 441:111-114.
14. Huang Y.H., Bao Y., Peng W., Goldberg M., Love K., Bumcrot D.A., et al. Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis. Proc Natl Acad Sci U S A 2009, 106:3426-3430.
15. Park K., Lee M.Y., Kim K.S., Hahn S.K. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate. Biomaterials 2010, 31:5258-5265.
16. Kim S.H., Mok H., Jeong J.H., Kim S.W., Park T.G. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate. Bioconjug Chem 2006, 17:241-244.
17. Urban-Klein B., Werth S., Abuharbeid S., Czubayko F., Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther 2005, 12:461-466.
18. Andersen M.O., Howard K.A., Paludan S.R., Besenbacher F., Kjems J. Delivery of siRNA from lyophilized polymeric surfaces. Biomaterials 2008, 29:506-512.
19. Mok H., Park T.G. Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA. Biopolymers 2008, 89:881-888.
20. Grimm D., Streetz K.L., Jopling C.L., Storm T.A., Pandey K., Davis C.R., et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 2006, 441:537-541.
21. Agrawal A., Min D.H., Singh N., Zhu H.H., Birjiniuk A., von Maltzahn G., et al. Functional delivery of siRNA in mice using dendriworms. Acs Nano 2009, 3:2495-2504.
22. Song E., Lee S.K., Wang J., Ince N., Ouyang N., Min J., et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003, 9:347-351.
23. Michalet X., Pinaud F.F., Bentolila L.A., Tsay J.M., Doose S., Li J.J., et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307:538-544.
24. Gao X., Cui Y., Levenson R.M., Chung L.W., Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22:969-976.
25. Gao X., Yang L., Petros J.A., Marshall F.F., Simons J.W., Nie S. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 2005, 16:63-72.
26. Medintz I.L., Uyeda H.T., Goldman E.R., Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 2005, 4:435-446.
27. Jamieson T., Bakhshi R., Petrova D., Pocock R., Imani M., Seifalian A.M. Biological applications of quantum dots. Biomaterials 2007, 28:4717-4732.
28. Segawa T., Sasagawa T., Yamazaki H., Sakaike J., Ishikawa H., Inoue M. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma. Cancer 1999, 85:2001-2010.
29. Burger R.A., Monk B.J., Kurosaki T., Anton-Culver H., Vasilev S.A., Berman M.L., et al. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 1996, 88:1361-1368.
30. Butz K., Ristriani T., Hengstermann A., Denk C., Scheffner M., Hoppe-Seyler F. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 2003, 22:5938-5945.
31. Hall A.H., Alexander K.A. RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J Virol 2003, 77:6066-6069.
32. Zhao M.X., Xia Q., Feng X.D., Zhu X.H., Mao Z.W., Ji L.N., et al. Synthesis, biocompatibility and cell labeling of L-arginine-functional β-cyclodextrin-modified quantum dot probes. Biomaterials 2010, 31:4401-4408.
33. Zhao M.X., Li J.M., Du L., Tan C.P., Xia Q., Mao Z.W., et al. Targeted cellular uptake and siRNA silencing by quantum-dot Nanoparticles coated with β-cyclodextrin coupled to amino acids. Chem Eur J 2011, 17:5171-5179.
34. Futaki S., Goto S., Sugiura Y. Membrane permeability commonly shared among arginine-rich peptides. J Mol Recognit 2003, 16:260-264.
35. Choi J.S., Nam K., Park J.Y., Kim J.B., Lee J.K., Park J.S. Enhanced transfection effi{ligature}ciency of PAMAM dendrimer by surface modifi{ligature}cation with L-arginine. J Control Release 2004, 99:445-456.
36. Kim W.J., Christensen L.V., Jo S., Yockman J.W., Jeong J.H., Kim Y.H., et al. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol Ther 2006, 14:343-350.
37. Davis M.E. Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin. Adv Drug Deliv Rev 2009, 61:1189-1192.
38. Qi L., Gao X. Quantum dot-amphipol nanocomplex for intracellular delivery and real-time imaging of siRNA. Acs Nano 2008, 2:1403-1410.
39. Jiang M., Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 2002, 21:6041-6048.